Premium
Vitrectomy in treatment naive diabetic macular edema
Author(s) -
Michalewska Z.,
Michalewski J.,
Bednarski M.,
Nawrocki J.
Publication year - 2016
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2016.0041
Subject(s) - vitrectomy , medicine , visual acuity , ophthalmology , epiretinal membrane , diabetic retinopathy , diabetic macular edema , macular edema , retinal , internal limiting membrane , edema , diabetes mellitus , surgery , macular hole , endocrinology
Summary Purpose To evaluate the potential benefit of vitrectomy in treatment naïve diabetic macular edema (DME). Methods A retrospective, clinical study of 44 consecutive patients with treatment‐naïve DME. SD‐OCT was performed before and after vitrectomy with inner limiting membrane peeling. Main outcome measures were final visual acuity, final central retinal thickness, need for repeated therapy. Results The follow up period ranged from 8 to 48 months. Overall, 31% of patients gained more than two lines and 84% of patients gained at least one Snellen line, and decreased by one Snellen line in one eye. Average central retinal thickness decreased from 595 to 266 μ m at the end of follow up (p < 0.001). Final visual acuity was inversely associated with duration of diabetes (p = 0.01) and presence of epiretinal membrane (p = 0.02) and initial visual acuity (0.03). Reappearance of macular edema was noted in three cases (6%), one of which received anti‐VEGF treatment. Conclusion Vitrectomy may result in long lasting, satisfactory anatomical and functional results in treatment‐naïve DME and may be more convenient than multiple intravitreal injections, especially for patients with transportation difficulties.